Register for email alerts and news feeds:
This journal | BMJ Group
rss
Gut 2006;55:757-759; doi:10.1136/gut.2005.085381
Copyright © 2006 BMJ Publishing Group Ltd & British Society of Gastroenterology.

COMMENTARY

Crohn's disease

Probiotics for Crohn’s disease: what have we learned?

C Prantera

Correspondence to:
Correspondence to:
Dr C Prantera
Division of Gastroenterology, Azienda Ospedaliera S Camillo-Forlanini, 00149 Roma, Italia; prantera@tin.it


Probiotics do not seem to be a therapeutic option for patients with Crohn’s disease, either in the acute phase or for maintenance

Keywords: Crohn’s disease; randomised controlled trial; probiotics; lactobacillus

The first 150 words of the full text of this article appear below.

A causative role of bacteria in Crohn’s disease (CD) has been surmised for a long time. Only in recent years however has there been a large body of evidence from genetic and bacteriological studies indicating that the intestinal flora is the essential factor in driving the Crohn’s inflammatory process in genetically susceptible individuals.1–5

The therapeutic arsenal for treating CD assumes the correctness of the above hypothesis. Thus immunosuppressors are used to reduce the host response and antibiotics are used to suppress the bacterial flora, with a consequent decreased activation of the gut immune system.6 Between the two strategies it should theoretically be better to remove the harmful cause instead of reducing the host defences by inducing a form of immunodeficiency that is susceptible to opportunistic infections.

If the intervention on the gut flora works, substituting antibiotics (which are heavily burdened by side effects) with probiotics is an appealing . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial
P Marteau, M Lémann, P Seksik, D Laharie, J F Colombel, Y Bouhnik, G Cadiot, J C Soulé, A Bourreille, E Metman, E Lerebours, F Carbonnel, J L Dupas, M Veyrac, B Coffin, J Moreau, V Abitbol, S Blum-Sperisen, and J Y Mary
Gut 2006 55: 842-847. [Abstract] [Full Text] [PDF]

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Cardiology Jobs

Gastroenterology Jobs